CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 77 filers reported holding CULLINAN ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,281,224 | -30.0% | 1,688,533 | -16.7% | 0.00% | -100.0% |
| Q2 2023 | $21,814,889 | -16.5% | 2,027,406 | -20.6% | 0.00% | 0.0% |
| Q1 2023 | $26,137,527 | -11.9% | 2,554,988 | -9.2% | 0.00% | 0.0% |
| Q4 2022 | $29,676,782 | -16.3% | 2,812,965 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $35,447,000 | +0.7% | 2,765,005 | +0.7% | 0.00% | 0.0% |
| Q2 2022 | $35,197,000 | +42.9% | 2,745,519 | +16.7% | 0.00% | 0.0% |
| Q1 2022 | $24,626,000 | -32.6% | 2,352,125 | -0.6% | 0.00% | 0.0% |
| Q4 2021 | $36,520,000 | -29.1% | 2,366,808 | +3.7% | 0.00% | 0.0% |
| Q3 2021 | $51,492,000 | +73.0% | 2,281,451 | +97.4% | 0.00% | 0.0% |
| Q2 2021 | $29,761,000 | -38.0% | 1,155,765 | +0.4% | 0.00% | 0.0% |
| Q1 2021 | $47,974,000 | – | 1,151,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |